Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Brooks

Showing results (821-830 of 854) with videos related to

Pageof 86
Sort By:
Communications Biology|September 13, 2022
Widespread subclinical cellular changes revealed across a neural-epithelial-vascular complex in choroideremia using adaptive opticsNancy Aguilera, Tao Liu, Andrew J Bower, et al.
Scientific Reports|February 9, 2017
Motivational, proteostatic and transcriptional deficits precede synapse loss, gliosis and neurodegeneration in the B6.Htt<sup>Q111/+</sup> model of Huntington's diseaseRobert M Bragg, Sydney R Coffey, Rory M Weston, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 24, 2008
N-((1S)-1-{[4-((2S)-2-{[(2,4-dichlorophenyl)sulfonyl]amino}-3-hydroxypropanoyl)-1-piperazinyl]carbonyl}-3-methylbutyl)-1-benzothiophene-2-carboxamide (GSK1016790A), a novel and potent transient receptor potential vanilloid 4 channel agonist induces urinary bladder contraction and hyperactivity: Part IKevin S Thorneloe, Anthony C Sulpizio, Zuojun Lin, et al.
Scientific Data|September 29, 2021
The "Narratives" fMRI dataset for evaluating models of naturalistic language comprehensionSamuel A Nastase, Yun-Fei Liu, Hanna Hillman, et al.
Bioorganic & Medicinal Chemistry Letters|November 23, 2007
The discovery of GSK221149A: a potent and selective oxytocin antagonistJohn Liddle, Michael J Allen, Alan D Borthwick, et al.
Human Molecular Genetics|January 9, 2009
Incomplete penetrance and phenotypic variability characterize Gdf6-attributable oculo-skeletal phenotypesMika Asai-Coakwell, Curtis R French, Ming Ye, et al.
Biorxiv : the Preprint Server for Biology|June 5, 2026
Targeting melanosome pH is an effective method for the treatment of oculocutaneous albinismSamuel J Grondin, Daniela St Pierre, David J Green, et al.
Journal of Medical Genetics|April 21, 2016
Cystic cerebellar dysplasia and biallelic LAMA1 mutations: a lamininopathy associated with tics, obsessive compulsive traits and myopia due to cell adhesion and migration defectsThierry Vilboux, May Christine V Malicdan, Yun Min Chang, et al.
British Journal of Pharmacology|April 27, 2005
Nonpeptidic urotensin-II receptor antagonists I: in vitro pharmacological characterization of SB-706375Stephen A Douglas, David J Behm, Nambi V Aiyar, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Ampyrone (4-Aminoantipyrine) is a Direct Agonist of Human Tyrosinase and Potential Therapeutic for Oculocutaneous Albinism and Disorders of HypopigmentationMonika B Dolinska, Yuhong Wang, Nathan P Coussens, et al.
Pageof 86

Showing results (821-830 of 854) with videos related to

Sort By:
Pageof 86
Communications Biology|September 13, 2022
Widespread subclinical cellular changes revealed across a neural-epithelial-vascular complex in choroideremia using adaptive opticsNancy Aguilera, Tao Liu, Andrew J Bower, et al.
Scientific Reports|February 9, 2017
Motivational, proteostatic and transcriptional deficits precede synapse loss, gliosis and neurodegeneration in the B6.Htt<sup>Q111/+</sup> model of Huntington's diseaseRobert M Bragg, Sydney R Coffey, Rory M Weston, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 24, 2008
N-((1S)-1-{[4-((2S)-2-{[(2,4-dichlorophenyl)sulfonyl]amino}-3-hydroxypropanoyl)-1-piperazinyl]carbonyl}-3-methylbutyl)-1-benzothiophene-2-carboxamide (GSK1016790A), a novel and potent transient receptor potential vanilloid 4 channel agonist induces urinary bladder contraction and hyperactivity: Part IKevin S Thorneloe, Anthony C Sulpizio, Zuojun Lin, et al.
Scientific Data|September 29, 2021
The "Narratives" fMRI dataset for evaluating models of naturalistic language comprehensionSamuel A Nastase, Yun-Fei Liu, Hanna Hillman, et al.
Bioorganic & Medicinal Chemistry Letters|November 23, 2007
The discovery of GSK221149A: a potent and selective oxytocin antagonistJohn Liddle, Michael J Allen, Alan D Borthwick, et al.
Human Molecular Genetics|January 9, 2009
Incomplete penetrance and phenotypic variability characterize Gdf6-attributable oculo-skeletal phenotypesMika Asai-Coakwell, Curtis R French, Ming Ye, et al.
Biorxiv : the Preprint Server for Biology|June 5, 2026
Targeting melanosome pH is an effective method for the treatment of oculocutaneous albinismSamuel J Grondin, Daniela St Pierre, David J Green, et al.
Journal of Medical Genetics|April 21, 2016
Cystic cerebellar dysplasia and biallelic LAMA1 mutations: a lamininopathy associated with tics, obsessive compulsive traits and myopia due to cell adhesion and migration defectsThierry Vilboux, May Christine V Malicdan, Yun Min Chang, et al.
British Journal of Pharmacology|April 27, 2005
Nonpeptidic urotensin-II receptor antagonists I: in vitro pharmacological characterization of SB-706375Stephen A Douglas, David J Behm, Nambi V Aiyar, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Ampyrone (4-Aminoantipyrine) is a Direct Agonist of Human Tyrosinase and Potential Therapeutic for Oculocutaneous Albinism and Disorders of HypopigmentationMonika B Dolinska, Yuhong Wang, Nathan P Coussens, et al.
Pageof 86